Over the past year, Exploration of Neuroprotective Therapy has achieved an increasing impact and larger number of citations. We sincerely thank everyone’s great support! At the beginning of 2023, we are thrilled to announce and recognize the winners of “Highly Cited Paper Award 2021-2022” to show our appreciation to those authors.
Criteria for selection and award:
● Original Articles and Reviews published in 2021-2022;
● Both regular and special issue submissions are considered;
● Citations are counted according to Web of Science (WOS) in 2021-2022;
● Prize for the author team: 300-1,000 USD, certificate of "Highly Cited Paper Award";
● Prize for the corresponding Guest Editor(s): 100-300 USD.
Winning Papers:
★ Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
María S. García-Gutiérrez, Francisco Navarrete, Ani Gasparyan, Jorge Manzanares*
★ Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Kamran Tariq, Bryan W. Luikart*
Special Issue: Cholesterol Dyshomeostasis in Neurological Diseases
★ Balancing cholesterol in the brain: from synthesis to disposal
Lydia Qian, Amanda B. Chai, Ingrid C. Gelissen*, Andrew J. Brown*
Special Issue: Cholesterol Dyshomeostasis in Neurological Diseases
Congratulations! We believe these articles will be more shining in the future.
In the following year, we will continue to set "Highly Cited Paper Award" to recognize the related authors. On behalf of the Editorial Board and Editorial Office, we warmly welcome more outstanding researchers to participate in and contribute to the journal. Our thriving journal is always open to you!
COPE Membership of Exploration of Neuroprotective Therapy Approved
ENT’s Editorial Board Member is actively promoting the journal’s Scopus inclusion news
Exploration of Neuroprotective Therapy accepted for Scopus
ENT promoted in the International Congress on Neurodegenerative Diseases ICND2024